Tenaya Therapeutics, Inc. (TNYA)
0.389
0.00 (0.00%)
USD |
NASDAQ |
Oct 23, 16:00
0.3897
0.00 (0.00%)
After-Hours: 20:00
Tenaya Therapeutics Profit Margin (Quarterly) : -3.91K% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.91K% |
| Date | Value |
|---|---|
| March 31, 2026 | -8.57K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -237.8% |
| Oncolytics Biotech, Inc. | -- |
| Sangamo Therapeutics, Inc. | -2.15K% |
| Sarepta Therapeutics, Inc. | -1.22% |
| Anixa Biosciences, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -107.1% |
| Return on Assets | -85.21% |
| Return on Invested Capital | -97.24% |
| Gross Profit Margin (Quarterly) | -52.97% |
| Operating Margin (Quarterly) | -1.88K% |
| Return on Net Operating Assets | -271.1% |